Clinical Trial Update: Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is currently recruiting to evaluate how aromatase inhibitor therapy affects glucose homeostasis and diabetes risk in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Diabetes Mellitus

Drugs mentioned

• Aromatase inhibitor therapy (aromatase inhibitor)

Snippet

Sponsor: Mayo Clinic | Conditions: HER2-Positive Breast Carcinoma | Status: RECRUITING